Table of Contents

company-logo

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. The company was incorporated in 2012 and is headquartered in Los Angeles, California.

Immix Biopharma Dividend Announcement

• Immix Biopharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Immix Biopharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Immix Biopharma Dividend History

Immix Biopharma Dividend Yield

Immix Biopharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Immix Biopharma stock? Use our calculator to estimate your expected dividend yield:

Immix Biopharma Financial Ratios

P/E ratio-2.68
PEG ratio0.14
P/B ratio2.13
ROE-86.48%
Payout ratio0.00%
Current ratio7.00
Quick ratio7.00
Cash Ratio6.14

Immix Biopharma Dividend FAQ

Does Immix Biopharma stock pay dividends?
Immix Biopharma does not currently pay dividends to its shareholders.
Has Immix Biopharma ever paid a dividend?
No, Immix Biopharma has no a history of paying dividends to its shareholders. Immix Biopharma is not known for its dividend payments.
Why doesn't Immix Biopharma pay dividends?
There are several potential reasons why Immix Biopharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Immix Biopharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Immix Biopharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Immix Biopharma a dividend aristocrat?
Immix Biopharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Immix Biopharma a dividend king?
Immix Biopharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Immix Biopharma a dividend stock?
No, Immix Biopharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Immix Biopharma stocks?
To buy Immix Biopharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Immix Biopharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.